Growing Up With Lead in Drinking Water May Dull Brain in Old Age
THURSDAY, Nov. 10, 2022 (HealthDay News) — Lead is known to damage young children’s brains, and a new study suggests the effects may still be apparent in old age.Researchers found that among nearly 1,100 older U.S. adults, those who grew up in cities…
Learn MoreRaise Med Dosages in Weeks After Heart Failure Crisis for Better Outcome: Study
THURSDAY, Nov. 10, 2022 (HealthDay News) — When people with heart failure wind up in the hospital, it tends to become a slippery slope: They are more likely to be readmitted or die within six months during this vulnerable period.Now, new research sho…
Learn MoreChildhood Lead Exposure Tied to Worse Cognitive Function in Late Life
THURSDAY, Nov. 10, 2022 (HealthDay News) — Exposure to lead in childhood is associated with worse cognitive functioning in late life, according to a study published in the Nov. 11 issue of Science Advances.Haena Lee, Ph.D., from Sungkyunkwan Universi…
Learn MoreAntiepileptic Med Use Increasing in Nursing Home Residents With Dementia
THURSDAY, Nov. 10, 2022 (HealthDay News) — Antiepileptic prescribing among nursing home residents with Alzheimer disease and related dementias (ADRD) is increasing, according to a study published online Nov. 9 in the Journal of the American Geriatric…
Learn MoreUrban-Dwelling Indigenous Young People Face Higher Burden of Skin Conditions
THURSDAY, Nov. 10, 2022 (HealthDay News) — A significant burden of atopic dermatitis and bacterial skin infections exists in urban-living Indigenous children and young people in high-income countries, according to a review published online Nov. 9 in …
Learn MoreIn Utero Air Pollution Exposure Tied to Infant Neurodevelopmental Delays
THURSDAY, Nov. 10, 2022 (HealthDay News) — Exposure to air pollution during pregnancy is significantly associated with delays in neurodevelopment, according to a study published online Nov. 9 in Developmental Medicine & Child Neurology.Ping Shih, fro…
Learn MoreHealth Care Access May Affect Receipt of Therapy in Ovarian Cancer
THURSDAY, Nov. 10, 2022 (HealthDay News) — Health care access (HCA) dimensions are associated with receipt of guideline-concordant therapy, but they do not fully explain racial disparities among patients with ovarian cancer, according to a study publ…
Learn MorePersonalized Screening for Kidney Disease Evaluated in T1DM
THURSDAY, Nov. 10, 2022 (HealthDay News) — For persons with type 1 diabetes, a personalized alternative to annual urinary albumin screening can reduce the time spent with undetected kidney disease, according to a study published online Nov. 2 in Diab…
Learn MoreRisk for Advanced Fibrosis Examined for Relatives of NAFLD Patients
THURSDAY, Nov. 10, 2022 (HealthDay News) — The risk for advanced fibrosis is increased for first-degree relatives of probands with nonalcoholic fatty liver disease (NAFLD) with advanced fibrosis, according to a study published online Nov. 1 in the Jo…
Learn MoreNab-Paclitaxel, Pembrolizumab Combo Active in Advanced Urothelial Cancer
THURSDAY, Nov. 10, 2022 (HealthDay News) — For patients with platinum-refractory or cisplatin-ineligible advanced urothelial cancer, the combination of nab-paclitaxel and pembrolizumab is promising, according to a study published online Nov. 1 in The…
Learn More